Aberdeen UK Equity Fund Z Accumulation

Performance History30/04/2018
Growth of 1,000 (GBP) Advanced Graph
Aberdeen UK Equity Fund Z Accumulation
Fund---13.0-0.8
+/-Cat----3.1-
+/-B’mrk----0.1-
 
Key Stats
NAV
11/05/2018
 GBX 142.83
Day Change 0.19%
Morningstar Category™ UK Flex-Cap Equity
IA (formerly IMA) Sector UK All Companies
ISIN GB00B13G1D11
Fund Size (Mil)
31/01/2020
 GBP 363.69
Share Class Size (Mil)
29/03/2018
 GBP 0.00
Max Initial Charge -
Ongoing Charge
31/07/2018
  0.10%
Investment Objective: Aberdeen UK Equity Fund Z Accumulation
To generate growth over the long term (5 years or more) by investing in UK equities (company shares).
Returns
Trailing Returns (GBP)11/05/2018
YTD1.51
3 Years Annualised-
5 Years Annualised-
10 Years Annualised-
12 Month Yield 2.92
Management
Manager Name
Start Date
Louise Kernohan
14/05/2018
Inception Date
03/02/2016
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
FTSE AllSh TR GBPFTSE AllSh TR GBP
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Aberdeen UK Equity Fund Z Accumulation31/12/2019
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock97.020.0097.02
Bond0.000.000.00
Property0.000.000.00
Cash2.980.012.97
Other0.010.000.01
Top 5 Regions%
United Kingdom96.95
United States3.01
Asia - Developed0.04
Canada0.00
Latin America0.00
Top 5 Sectors%
Financial Services18.80
Healthcare17.29
Industrials15.03
Consumer Defensive14.89
Communication Services10.12
Top 5 HoldingsSector%
AstraZeneca PLCHealthcareHealthcare5.12
Diageo PLCConsumer DefensiveConsumer Defensive4.42
AVEVA Group PLCTechnologyTechnology4.40
RELX PLCCommunication ServicesCommunication Services4.04
Prudential PLCFinancial ServicesFinancial Services3.86
Aberdeen UK Equity Fund Z Accumulation

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites